APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

INDICATIONS AND USAGE Hydrocodone bitartrate and acetaminophen tablets are indicated for the relief of moderate to moderately severe pain.

RedPharm Drug Inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] nausea` `[4] dyspnoea` `[5] diarrhoea` `[6] off label use` `[7] pain` `[8] dizziness` `[9] headache` `[10] asthenia`

2 hours ago

OVAL WHITE 3604 V

2 hours ago

3604 V OVAL WHITE

HOW SUPPLIED Hydrocodone Bitartrate and Acetaminophen Tablets, USP 5 mg/325 mg are supplied as white with orange specks, capsule-shaped, scored tablets, debossed “3604” on one side and debossed “V” on the reverse side. The tablets are supplied in containers of 10, 100, 500 and 1000. Storage: Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure. A Schedule CIII Narcotic.

More pills like OVAL 3604 V

Related Pills

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

RedPharm Drug Inc.

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

RedPharm Drug Inc.

Acetaminophen 325 MG Hydrocodone Bitartrate 5 MG Oral Tablet

Par Pharmaceutical

Acetaminophen 325 MG Hydrocodone Bitartrate 5 MG Oral Tablet

Par Pharmaceutical

Acetaminophen 325 MG Hydrocodone Bitartrate 5 MG Oral Tablet

Par Pharmaceutical

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

Aphena Pharma Solutions - Tennessee, Inc.

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

Aphena Pharma Solutions - Tennessee, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site